|
|
Expression of autophagy-associated protein LC3II in non-small cell lung cancer and its correlation withradiotherapy sensitivit |
GAO Zongyi1,2, HE Shuang3, LI Yangyang3, WEN Feifei3, GAO Xiangqian3, WU Shuhua3 |
1 Department of Pathology, Basic Medical University, Binzhou Medical University, Yantai 264003, P.R.China; 2 Department of Radiotherapy, Binzhou Central Hospital; 3 Department of Pathology, Binzhou Medical University Hospital |
|
|
Abstract Objective To study the expression of autophagy-related protein LC3II in non-small cell lung cancer (NSCLC, including lung adenocarcinoma and squamous cell carcinoma), and elucidate the influence and significance of autophagy expression on lung cancer radiotherapy curative effect. Methods Immunohistochemical method was used to detect the expression of LC3-II in 243 cases of non-small cell lung cancer based on retrospective study and 48 cases of normal lung tissue, and analyze the the relationship with expression of LC3II and clinicopathological factors. Dividing the patients into four groups according to the curative effect, to explore the relationship between the expression of LC3II and radiotherapy sensitivity. Results ① The positive expression of LC3II in the adenocarcinoma group and the squamous cell carcinoma group was lower than that in normal lung tissue.② High LC3II expression was found to be significantly correlated with tumor size, necrosis and TNM grade (P<0.05) , but not with age, sex and pathological type. ③ Compared with all patients with positive expression of LC3II (52.7%), the positive rate of LC3II expression in CR group was the lowest (40.9%), whereas PD group was the highest (71.9%). Conclusion Autophagy-related protein LC3II was down-regulated in lung adenocarcinoma and squamous cell carcinoma, and associated with large size, necrosis and TNM grade, which may be related with the development of lung cancer. The high expression of autophagy is closely related to lung adenocarcinoma, squamous cell carcinoma and the radiation resistance, which would affect the efficacy of radiotherapy.
|
Received: 21 November 2018
|
|
|
|
|
[1] 陈万青,张思维, 邹小农. 中国肺癌发病死亡的估计和流行趋势研究[J]. 中国肺癌杂志, 2010,13(5):488-493. [2] Morimoto M, Okishio K, Akira M, et al . Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer [J] . Clin Lung Cancer, 2017, 18(2):117-127. [3] Zhang X, Ji J, Yang Y, et al. Stathmin1 increases radioresistance by enhancingautophagy in non-small-cell lung cancer cells [J]. Onco Targets Ther,2016, 9:2565-2574. [4] Kimura T, Jia J, Claude-Taupin A, et al. Cellular and molecular mechanism for secretory autophagy [J]. Autophagy, 2017,13(6):1084-1085. [5] Chen T, Stephens P A, Middleton F K, et al. Targeting the S and G2 checkpoint to treat cancer [J] . Drug discovery today,2012, 17 (5-6):194-202. [6] Hu J, Meng Y, Zhang Z, et al. MARCH5 RNA promotes autophagy, migration, and invasion of ovarian cancer cells [J] . Autophagy,2017 ,13(2):333-344. [7] Wang B, Zhou T Y, Nie C H, et al. Bigelovin, a sesquiterpene lactone, suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation in liver cancer[J]. Biochem Biophys Res Commun, 2018,499(2):156-163. [8] Walker A, Singh A, Tully E, et al.Nrf2 signaling and autophagy are complementary in protecting breast cancer cells during glucose deprivation[J]. Free Radic Biol Med,2018,120:407-413. [9] Guo X, Fu Y, Wang Z, et al. Di-2-pyridylhydrazone Dithiocarbamate Butyric Acid Ester Exerted Its Proliferative Inhibition against Gastric Cell via ROS-Mediated Apoptosis and Autophagy[J]. Oxid Med Cell Longev, 2018,2018:4950705 [10] Wu S,Sun C,Tian D,et al.Expression and clinical significances of Beclin1,LC3 and mTOR in colorectal cancer [J].Int J Clin Exp Pathol,2015,8(4):3882-3891. [11] He C,Levine B.The Beclin1 interactome [J].Curr Opin Cell Biol,2010, 22(2):140-149. [12] 吴淑华,胡金龙,何双,等. 大肠癌中Beclin1、LC3和mTOR的表达及意义[J].临床与实验病理学,2014,30 (12):1333-1338. [13] Hsieh M J,Lin C W,Yang S F,et al.A Combination of Pterostilbene with Autophagy Inhibitors Exerts Efficient Apoptotic Characteristics in Both Chemosensitive and Chemoresistant Lung Cancer Cells [J].Toxicol Sci,2014,137(1):65-75. [14] Tam S Y,Wu V W,Law H K.Influence of autophagy on the efficacy of radiotherapy [J].Radiat Oncol,2017,12(1):57. |
[1] |
ZHAO Shengwen, SU Jin, DING Yuexia. Pharmacoeconomic evaluation of gefitinib in the treatment of non-small cell lung cancer[J]. 滨州医学院学报, 2019, 42(5): 373-376. |
[2] |
JIA Teng, GU Xiaojie, LIU Hongjian, XU Haitao, ZHANG Qingguang. Postoperative adjuvant chemotherapy for stage IB non-small-cell lung cancer:A systematic review and meta-analysis[J]. 滨州医学院学报, 2019, 42(4): 281-284. |
|
|
|
|